A detailed history of Cortland Associates Inc transactions in Pfizer Inc stock. As of the latest transaction made, Cortland Associates Inc holds 7,367 shares of PFE stock, worth $188,963. This represents 0.03% of its overall portfolio holdings.

Number of Shares
7,367
Previous 7,284 1.14%
Holding current value
$188,963
Previous $203,000 4.93%
% of portfolio
0.03%
Previous 0.03%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$27.7 - $31.39 $2,299 - $2,605
83 Added 1.14%
7,367 $213,000
Q2 2024

Jul 29, 2024

BUY
$25.26 - $29.6 $183,993 - $215,606
7,284 New
7,284 $203,000
Q4 2023

Jan 30, 2024

BUY
$26.13 - $33.94 $1,959 - $2,545
75 Added 1.03%
7,342 $211,000
Q3 2023

Oct 27, 2023

SELL
$32.09 - $37.51 $2,214 - $2,588
-69 Reduced 0.94%
7,267 $241,000
Q2 2023

Aug 03, 2023

SELL
$36.12 - $41.79 $51,796 - $59,926
-1,434 Reduced 16.35%
7,336 $269,000
Q1 2023

Apr 20, 2023

BUY
$39.39 - $51.28 $14,062 - $18,306
357 Added 4.24%
8,770 $357,000
Q4 2022

Jan 27, 2023

SELL
$41.75 - $54.5 $10,437 - $13,625
-250 Reduced 2.89%
8,413 $0
Q3 2022

Nov 01, 2022

BUY
$43.76 - $53.42 $350 - $427
8 Added 0.09%
8,663 $379,000
Q2 2022

Jul 22, 2022

BUY
$46.53 - $55.17 $39,922 - $47,335
858 Added 11.0%
8,655 $454,000
Q1 2022

May 03, 2022

SELL
$45.75 - $56.69 $4,575 - $5,669
-100 Reduced 1.27%
7,797 $404,000
Q4 2021

Feb 01, 2022

BUY
$41.32 - $61.25 $8,305 - $12,311
201 Added 2.61%
7,897 $466,000
Q4 2020

Feb 02, 2021

SELL
$33.47 - $42.56 $5,020 - $6,384
-150 Reduced 1.91%
7,696 $283,000
Q2 2020

Jul 23, 2020

BUY
$30.12 - $36.54 $1,506 - $1,827
50 Added 0.64%
7,846 $257,000
Q1 2020

Apr 30, 2020

SELL
$27.03 - $38.62 $891 - $1,274
-33 Reduced 0.42%
7,796 $254,000
Q4 2019

Jan 31, 2020

BUY
$32.92 - $37.36 $2,732 - $3,100
83 Added 1.07%
7,829 $307,000
Q1 2019

Apr 26, 2019

SELL
$37.5 - $41.2 $212,100 - $233,027
-5,656 Reduced 42.2%
7,746 $329,000
Q4 2018

Feb 01, 2019

BUY
$38.47 - $43.86 $2,692 - $3,070
70 Added 0.53%
13,402 $585,000
Q3 2018

Oct 30, 2018

SELL
$34.47 - $41.81 $1,240 - $1,505
-36 Reduced 0.27%
13,332 $588,000
Q2 2018

Jul 16, 2018

SELL
$32.98 - $35.16 $10,157 - $10,829
-308 Reduced 2.25%
13,368 $485,000
Q1 2018

Apr 26, 2018

BUY
$31.91 - $37.02 $3,669 - $4,257
115 Added 0.85%
13,676 $485,000
Q4 2017

Jan 24, 2018

BUY
$33.26 - $35.29 $19,889 - $21,103
598 Added 4.61%
13,561 $491,000
Q3 2017

Oct 25, 2017

BUY
$31.0 - $34.15 $401,853 - $442,686
12,963
12,963 $463,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $144B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Cortland Associates Inc Portfolio

Follow Cortland Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cortland Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cortland Associates Inc with notifications on news.